1. Introduction {#s0005}
===============

High-risk types of human papillomavirus (HPV), the most common sexually transmitted infection (STI) internationally, can lead to development of cervical cancer as well as genital warts, anal, penile and oropharyngeal cancers ([@bb0045]). In 2006, the United States Food and Drug Administration (FDA) approved the quadrivalent vaccine for the prevention of HPV types 6, 11, 16 and 18 ([@bb0145]) associated with over of 70% of all cervical cancer cases and 90% of genital warts cases ([@bb0115]). In 2008, the FDA further approved the bivalent HPV vaccination which prevents HPV types 16 and 18 protecting against cervical cancer but not strains of HPV that cause genital warts ([@bb0145], [@bb0150]). Recently, a nonavalent vaccine has been licensed for use in the European Union and the United States (US), providing protection against five additional high-risk types of HPV ([@bb0050]). Widespread use of this vaccine has not yet begun in the United Kingdom (UK), however, it is currently the only vaccine being administered in the US. Now, almost all high-income countries have one of the HPV vaccines available to girls and young women, although the choice of vaccine, the cohorts it is offered to, the way it is administered and the cost, varies. In the US, the HPV vaccine is predominantly available through physicians\' clinics and medical centres, while in the UK and Australia, publically funded school-based programs offer the vaccine free to girls age 12--13. In 2007, Australia was the first country internationally to launch publically funded school-based programs, with the UK launching their program a year later in 2008. Australia also had catch-up programs targeting young women in schools and the community, and the UK had a similar catch-up program from 2008 to 2010.

Given that the primary target population for HPV vaccination programs is girls aged 9--13 years, typically before the initiation of sexual activity ([@bb0180]), parental knowledge and attitudes play an important role in the success of vaccination as consent is usually required for their adolescent children to be vaccinated. Research aimed at understanding HPV vaccine uptake has demonstrated that uptake of the HPV vaccine is generally high, however parents and girls often have insufficient knowledge and understanding about and have varying attitudes towards vaccination ([@bb0070]). Alongside this, several studies conducted across different settings have aimed to examine factors influencing HPV vaccine uptake. Findings from these studies are wide-ranging, however, parental intentions have been shown to consistently be a strong predictor of their children\'s HPV vaccine uptake ([@bb0005], [@bb0120]).

The understanding of parental psychosocial determinants that influence HPV vaccine initiation is a growing area of research ([@bb0010], [@bb0085], [@bb0090], [@bb0140]), although no studies have directly compared countries that use different methods of administering the vaccine, such as school-based or non-school-based programs. Using online survey data collected across three countries, this study examined parents of 9--17 year-old girls in the US, UK and Australia to identify country-specific factors which are associated with their daughters\' vaccination status (HPV vaccine initiation). It also compared attitude differences between countries and by HPV vaccination knowledge by using identical knowledge and attitude variables in order to help better identify how parents\' attitudes and knowledge play a role in vaccination participation internationally.

2. Material and methods {#s0010}
=======================

2.1. Participants {#s0015}
-----------------

Participants (*n* = 12,259) from the US, UK and Australia were directed to a web-based survey by Survey Sampling International (SSI). SSI has existing online panels of participants who sign up to take part in market research for points which go towards a small reward (e.g. coupons and discounts). Quotas were set to ensure adequate representation of different age-groups and genders. The initial target sample for the survey was 2400 participants aged 18--70 years with approximately 800 participants from each country, including an equal number of men and women. Participants meeting these criteria were recruited to the survey. Participants were asked additional demographic questions including whether they had a daughter aged 9--17 years of age (the HPV vaccination age-range). From this information, survey data was analysed from participants who indicated they had at least one daughter in the HPV vaccination age-range. Ethical approval was obtained from human research ethics committees at Indiana University, USA, University College London, UK and the University of Sydney, Australia.

2.2. Measures {#s0020}
-------------

Participants were given information which included the purpose of the study, confidentiality and anonymity information and contact details for researchers in their country. Initially participants were asked their age, gender and country of residence to determine if they were eligible to take part in the survey, based on the quota of *n* = 400 men and *n* = 400 women from each country. Before participants began the questions on HPV knowledge they were asked 'how many daughters do you have between the ages of 9 and 17'. If participants had a daughter or daughters in this age-range they were asked for their daughters\' specific age(s) and how many of those had received at least one dose of the HPV vaccine. If at least one of the participant\'s daughters had been vaccinated, the parent was classified as "vaccinated" for the outcome variable. All participants were then asked questions on their knowledge of HPV (16 questions) and HPV vaccination (7 questions), which were later validated ([@bb0160]). Response options for the two sets of knowledge questions were True/False/Don\'t know, and data on knowledge of HPV, HPV vaccination and HPV testing were analysed and results published ([@bb0030], [@bb0105]).

If participants answered that they had a daughter in the vaccination age-range they were further directed to a set of purposely designed attitude statements on HPV and HPV vaccination ([Supplementary Table 1](#ec0005){ref-type="supplementary-material"}) which were derived from a UK survey ([@bb0100]). Statements were directed specifically to either participants with at least one unvaccinated daughter eligible for HPV vaccination (14 attitude statements) or participants with at least one daughter who had received one or more doses of vaccine (8 attitude statements), with both sets of parents receiving the same eight attitude statements (with the wording only differing slightly based on context). Parents with at least one unvaccinated daughter were given an additional six attitude statements. Response options for the attitude statements were given as a 5-point Likert scale (Strongly disagree, Disagree, Neither disagree nor agree, Agree, Strongly agree). Data analysis on attitudes to HPV and to HPV vaccination was performed on the responses of participants who indicated that they had a daughter who was of vaccination age.

Participants were removed from the final analysis if they did not know whether their daughter had received the HPV vaccination, if they had never heard of the HPV vaccination or if they did not answer any of the parental attitude statements on HPV or the HPV vaccination (*n* = 146).

2.3. Statistical analysis {#s0025}
-------------------------

Responses to attitude items were collapsed into three categories: Disagree (Strongly disagree and Disagree), Neither disagree nor agree, and Agree (Agree and Strongly agree). Parental HPV vaccination knowledge scores (ranging from 0 to 7) were combined into three categories: low (0--2 correct responses), medium (3--4), and high (5 +). Chi-square tests were conducted initially to investigate the association between knowledge, attitudes and daughters\' vaccination status.

The association between the proportion with daughters "not vaccinated" and the demographic, knowledge (as a continuous measure) and attitude variables were investigated using logistic regression with odds ratios reported from these models. Initially all variables were fitted univariately with the outcome and then a multivariable model was constructed. We decided a priori on the most important variables to be included in the model and included all the attitude variables regardless of significance because of the small sample size. For the model building, all demographic factors were fitted and then backwards elimination applied. The knowledge measures were then included and backwards elimination used. Finally, all attitude variables were added to produce the final model. The attitude regarding genital warts was only measured in two countries so it was fitted separately where the data was available and adjusted for all factors in the final model. This is because at the time of data collection the US and Australia offered Gardasil which protects against genital warts and the UK offered Cervarix which did not protect against genital warts. Fractional polynomials were used to assess the linearity of the association between the continuous knowledge scores and vaccination status. Likelihood ratio *p*-values were used to assess statistical significance with *p* \< 0.05 considered significant.

Data were analysed using SPSS V.21 (IBM, Armonk, NY). The logistic regression models were conducted in Stata 14 ([@bb0130]. Stata Statistical Software: Release 14. College Station).

3. Results {#s0030}
==========

The survey had a 62% response rate, as a total of 12,259 men and women were directed to the HPV survey, 3959 were deemed eligible and invited to take part, and 2442 participants completed the survey. From that sample, 325 participants identified themselves as parents of daughters aged 9--17 years. Parents who did not know their daughters\' vaccination status, had never heard of HPV or did not answer any questions or attitude statements were excluded, leaving 179 parents in the analysed sample ([Fig. 1](#f0005){ref-type="fig"}). Participant characteristics are shown in [Table 1](#t0005){ref-type="table"}. Overall, 59.2% of parents reported that their daughter had received the HPV vaccine.Fig. 1Participant recruitment.^⁎^Participants outside the age range 18--70 years.^⁎⁎^Data involved inconsistencies therefore survey may not have been completed properly.Fig. 1Table 1Participant characteristics (*n* = 179).Table 1CharacteristicUSA (*n* = 67)UK (*n* = 59)Australia (*n* = 53)Age \[mean (SD)\]37.8 (9.97)39.4 (8.72)42.5 (8.92)Gender \[*n* (%)\] Men21 (31.3)21 (35.6)24 (45.3) Women46 (68.7)38 (64.4)29 (54.7)Daughter\'s vaccination status \[*n* (%)\] Vaccinated29 (43.3)37 (62.7)40 (75.5) Not vaccinated38 (56.7)22 (37.3)13 (24.5)Ethnicity[a](#tf0005){ref-type="table-fn"} \[*n* (%)\] Majority50 (74.6)50 (84.7)42 (79.2) Minority17 (25.4)9 (15.3)11 (20.8)Education[b](#tf0010){ref-type="table-fn"} \[*n* (%)\] High49 (73.1)29 (49.2)19 (35.8) Low18 (26.9)30 (50.8)34 (64.2)Relationship status \[*n* (%)\] Married/partner49 (73.1)46 (78.0)43 (81.1) Dating/single18 (26.9)13 (22.0)10 (18.9)Religious engagement \[*n* (%)\] Often34 (50.7)13 (22.0)12 (22.6) Sometimes20 (29.9)8 (13.6)7 (13.2) Rarely or never13 (19.4)38 (64.4)34 (64.2)Average HPV knowledge score \[mean (SD)\][c](#tf0015){ref-type="table-fn"}9.75 (4.02)9.25 (3.43)9.47 (2.99)Average HPV vaccination knowledge score \[mean (SD)\][d](#tf0020){ref-type="table-fn"}4.18 (1.72)4.10 (1.64)4.34 (1.07)[^1][^2][^3][^4]

3.1. Factors associated with non-vaccinated status across the entire sample {#s0035}
---------------------------------------------------------------------------

The strongest factor associated with daughters\' vaccination status across the entire sample was parents\' HPV knowledge (*p* \< 0.001; [Table 2](#t0010){ref-type="table"}). As shown in [Fig. 2](#f0010){ref-type="fig"}, parents\' HPV knowledge scores displayed a non-linear relationship; parents with low knowledge scores and parents with high knowledge scores were less likely to have vaccinated their daughters. HPV vaccination specific knowledge was also a significant univariate factors associated with of vaccination status (*p* \< 0.05) and displayed a non-linear relationship; parents with lower levels of vaccination specific knowledge and very high levels of vaccination specific knowledge were also less likely to have vaccinated their daughters. Parents\' demographic characteristics including their country of origin (OR = 2.204, 95% CI 1.07--4.50; *p* \< 0.05) and gender (OR = 0.492 95% CI \[0.259, 0.935\], *p* \< 0.05) were also factors associated with non-vaccination in our sample, with parents in the US and men (across all countries) being less likely to vaccinate their daughters.Fig. 2Estimated proportion of daughters not vaccinated as a quadratic function of parents\' HPV knowledge.Fig. 2Table 2Factors associated with non-vaccination of daughters (9--17 years) with HPV vaccine (*n* = 179).Table 2FactorsAgreementNo. of parentsUnivariate modelMultivariate modelAdjusted OR (95% CI)*p*-ValueAdjusted OR (95% CI)*p*-Value*Demographics*Age--1791.000 (0.969, 1.032)0.9892Gender0.0278 Male--660.492 (0.259, 0.935)[⁎](#tf0040){ref-type="table-fn"} Female (ref)1131Country0.00120.1039 USA672.204 (1.077, 4.507)[⁎](#tf0040){ref-type="table-fn"}1.337 (0.567, 3.154) Australia--530.547 (0.241, 1.239)0.496 (0.191, 1.288) UK (ref)5911Qualifications0.0958 High school grad or below--820.599 (0.327, 1.099) Uni/college or above (ref)971Ethnicity0.7329 Other--371.136 (0.547, 2.362) White (ref)1421Relationship0.5317 Single/dating--410.796 (0.387, 1.634) Partner/married (ref)1381Religious services attendance0.5291 Sometimes--351.467 (0.660, 3.259) Often591.372 (0.697, 2.703) Rarely or never (ref)851  *Knowledge*HPV knowledge--179\< 0.001\< 0.001 Linear term0.454 (0.296, 0.695)[⁎⁎](#tf0045){ref-type="table-fn"}0.431 (0.259, 0.716)[⁎⁎](#tf0045){ref-type="table-fn"} Square term1.051 (1.026, 1.077)[⁎⁎](#tf0045){ref-type="table-fn"}1.055 (1.026, 1.086)[⁎⁎](#tf0045){ref-type="table-fn"}HPV vaccination knowledge--1790.0042 Linear term2.813 (0.585, 13.515) Square term0.561 (0.331, 0.950)[⁎](#tf0040){ref-type="table-fn"} Cube term1.067 (1.015, 1.122)[⁎](#tf0040){ref-type="table-fn"}  *Attitudes*[a](#tf0025){ref-type="table-fn"}Having the HPV vaccination might make girls more like to have sexDisagree (ref)11110.477510.3674Neither agree nor disagree421.167 (0.571, 2.387)1.144 (0.366, 3.576)Agree260.628 (0.252, 1.567)0.417 (0.096, 1.812)Girls who have the HPV vaccination might be more likely to have unprotected sexDisagree (ref)8410.878510.7052Neither agree nor disagree631.103 (0.569, 2.139)0.907 (0.332, 2.481)Agree320.882 (0.382, 2.039)1.578 (0.375, 6.636)Cervical cancer is not something I worry about for my daughterDisagree (ref)8810.62610.9925Neither agree nor disagree550.776 (0.390, 1.543)0.964 (0.415, 2.240)Agree360.710 (0.319, 1.580)0.938 (0.310, 2.839)My daughter may one day be at risk of getting HPVDisagree (ref)1810.095110.0992Neither agree nor disagree470.478 (0.155, 1.477)0.912 (0.168, 4.965)Agree1141.048 (0.386, 2.850)2.454 (0.582, 10.357)I am very worried about the side effects of the HPV vaccination for my daughterDisagree (ref)5210.122110.1406Neither agree nor disagree601.500 (0.685, 3.283)2.503 (0.915, 6.848)Agree672.184 (1.022, 4.665)2.245 (0.833, 6.055)It is like that my daughter will get HPV one dayDisagree (ref)6110.965710.504Neither agree nor disagree921.013 (0.525, 1.956)1.227 (0.509, 2.959)Agree260.900 (0.351, 2.305)0.627 (0.180, 2.181)It is possible that my daughter may get HPV in the futureDisagree (ref)1610.050210.104Neither agree nor disagree680.248 (0.077, 0.797)0.175 (0.030, 1.013)Agree950.303 (0.097, 0.942)0.191 (0.036, 1.000)Genital warts are not something I worry about for my daughter[b](#tf0030){ref-type="table-fn"}Disagree (ref)5510.091310.105[c](#tf0035){ref-type="table-fn"}Neither agree nor disagree410.683 (0.302, 1.544)0.674 (0.187, 2.421)Agree240.321 (0.111, 0.932)0.185 (0.036, 0.941)[⁎](#tf0040){ref-type="table-fn"}[^5][^6][^7][^8][^9]

3.2. Parental attitude differences by country {#s0040}
---------------------------------------------

As shown in [Table 3](#t0015){ref-type="table"} (and in [Supplementary Table 2](#ec0010){ref-type="supplementary-material"}), among parents with unvaccinated daughters, worry about the side-effects of the vaccine was significantly more prevalent in the US than the UK or Australia (US 60.5% agree, UK 36.4%, AUS 15.4%, *p* \< 0.05). Non-vaccinating parents from the US were also more likely to agree that getting all 3 doses of the HPV vaccine would be a big hassle (US 21.1% agree, UK 0%, AUS 7.7%, *p* \< 0.05) and that the HPV vaccine is so new that they would want to wait before deciding to get it for their daughter (US 44.7% agree, UK 22.7%, AUS 7.7%, *p* \< 0.05).

Parents with vaccinated daughters from the US were more likely than their Australian counterparts to agree that genital warts are not something they worry about for their daughters now that they are vaccinated (US 41.4%, AUS 15.0%, p \< 0.05). UK parents were not given this question.Table 3Significant parental attitude differences by country.Table 3Unvaccinated daughters (*n* = 73)Vaccinated daughters (*n* = 106)AttitudesCountryAgreement (%)[a](#tf0050){ref-type="table-fn"}*p*-Value[b](#tf0055){ref-type="table-fn"}AttitudesCountryAgreement (%)[a](#tf0050){ref-type="table-fn"}*p*-Value[b](#tf0055){ref-type="table-fn"}DisagreeNeither agree nor disagreeAgreeDisagreeNeither agree nor disagreeAgreeI would be very worried about the side effects of the HPV vaccination for my daughterUSA13.226.360.50.029Now that my daughter has been vaccinated, genital warts are not something I worry about for herUSA37.920.741.40.025UK22.740.936.4UK[c](#tf0060){ref-type="table-fn"}------AUS46.238.515.4AUS40.045.015.0Getting my daughter all 3 doses of the HPV vaccine would be a big hassleUSA57.921.121.10.042UK54.545.50.0AUS76.915.47.7The HPV vaccine is so new that I want to wait before deciding to get it for my daughterUSA26.328.944.70.014UK40.936.422.7AUS76.915.47.7[^10][^11][^12]Table 4Significant parental attitude differences by HPV vaccination specific knowledge scores.Table 4Unvaccinated daughters (*n* = 73)Vaccinated daughters (*n* = 106)AttitudesHPV knowledge scoreAgreement (%)[a](#tf0065){ref-type="table-fn"}*p*-Value[b](#tf0070){ref-type="table-fn"}AttitudesHPV knowledge scoreAgreement (%)[a](#tf0065){ref-type="table-fn"}*p*-Value[b](#tf0070){ref-type="table-fn"}DisagreeNeither agree nor disagreeAgreeDisagreeNeither agree nor disagreeAgreeI would want to be on the safe side and vaccinate my daughter0--20.072.727.3\< 0.001Although my daughter has had the HPV vaccination, she may one day be at risk of getting HPV0--211.166.722.20.0443--432.423.544.13--414.923.461.75 +11.114.874.15 +4.034.062.0Although my daughter has had the HPV vaccination, it is still possible that she may get HPV in the future0--211.177.811.10.0233--48.538.353.25 +0.038.062.0[^13][^14]

3.3. Association between HPV vaccination knowledge and parental attitudes {#s0045}
-------------------------------------------------------------------------

The significant associations between parental attitudes and HPV vaccination knowledge are presented in [Table 4](#t0020){ref-type="table"} (and in [Supplementary Table 3](#ec0015){ref-type="supplementary-material"}). Compared to parents of unvaccinated daughters with low knowledge scores, those with higher knowledge scores were more likely to believe that they want to be on the safe side and vaccinate their daughters (low knowledge = 27.3%, medium = 44.1%, high = 74.1%; *p* ≤ 0.001). Compared to parents of vaccinated daughters with low knowledge scores, those with higher knowledge scores believed that their daughters may still one day be at risk of getting HPV (low knowledge = 22.2% vs medium = 61.7% vs high = 62.0%; *p* \< 0.05) and that it is still possible for their daughters to get HPV in the future (low knowledge = 11.1% vs medium = 53.2% vs high = 62.0%; *p* \< 0.05).

4. Discussion {#s0050}
=============

Our study contributes to the literature by providing an international comparison of correlates of HPV vaccination uptake using identical knowledge and attitude variables across three countries. It found that shortly after introduction of the HPV vaccine, HPV knowledge level was associated with vaccination uptake, and parental attitudes differed by both country and level of HPV vaccination knowledge.

Across all three countries (US, UK and Australia), parents were more likely to have chosen not to vaccinate their daughters if they scored very low or very high on HPV knowledge and HPV vaccination specific knowledge questions. Parents of unvaccinated daughters with higher vaccination knowledge scores in our sample did, however, express attitudes favouring vaccinating their daughters in the future. Evidence varies across a number of countries and settings as to whether knowledge impacts vaccination uptake. Some studies report a correlation between higher levels of parental HPV knowledge and vaccine acceptability ([@bb0020], [@bb0175]), and others reporting no correlation ([@bb0010], [@bb0025], [@bb0040], [@bb0065], [@bb0095]). We also found that country of origin and gender were associated with HPV vaccine initiation with parents residing in the US and males in all three countries being less likely to have daughters who were vaccinated (where vaccination is not part of a school-based program).

In regards to parental attitudes, we found that parents of unvaccinated daughters in the US were more worried about the side effects of the HPV vaccine than parents of unvaccinated girls in the UK and Australia. This supports the finding from this study that more parents with daughters in the vaccination age-range from the US in our sample compared to the UK and Australia were not vaccinated. Previous studies have shown that parents in the US express serious concerns about vaccines for their children. A study conducted in the US with 1552 parents found that more than half (54%) still worry about vaccine side effects ([@bb0055]), and overall, 11.5% of parents had refused at least one vaccine their doctor had recommended, with the HPV vaccine being the most commonly refused (56%). Furthermore, a recent systematic review on barriers to the HPV vaccination in the US found that parental attitudes to the vaccine included the need for parents in the US to receive more information before vaccinating their child, and concerns about adverse effects of the vaccine ([@bb0075]). Parents from the US with unvaccinated daughters more often believed that getting all three doses of the HPV vaccine would be a significant obstacle, not surprisingly as the HPV vaccine distribution in the US is predominantly available through physicians\' clinics and medical centres, whereas in the UK and Australia free school-based and catch-up programs are offered ([@bb0170]). Parents of unvaccinated daughters from the US also believed that the vaccine was so new that they would want to wait before deciding to get it for their daughter. This finding was unexpected given that advertising about HPV contributed to an increased awareness of HPV in the US at the time of data collection ([@bb0015], [@bb0080]). It is important to note however, that this survey was conducted in 2011, and therefore attitudes of US parents now may differ.

Parental vaccination knowledge was also shown to be associated with attitudes towards the HPV vaccine. Our study found that parents of unvaccinated daughters with higher vaccination knowledge scores expressed attitudes that they intended to vaccinate their daughters, and be on the safe side. This finding might help explain why many of the parents with higher HPV knowledge and HPV vaccine knowledge scores in our sample had daughters who had not yet been vaccinated. For parents of vaccinated daughters with higher knowledge scores, they understood that although they have vaccinated their daughters they may still be at risk of getting HPV in the future. This demonstrates that vaccinated parents in our study with higher HPV vaccination knowledge had better understanding of the risks of HPV.

By recruiting parents online through a wider survey, this study was able to directly compare parental attitudes across three countries, although recruitment using online panel samples and the use of quotas to ensure adequate representation of different age-groups and genders means that the sample may not be representative of parents in the US, UK and Australia. The use of quotas did, however, ensure that respondents with lower levels of education were well represented as shown with our sample. Furthermore, using a survey design allowed us to be able to separate parents who had vaccinated and unvaccinated daughters in our analysis to determine factors associated with vaccination status and compare attitudinal differences within the groups, as survey questions were tailored to parents based on their daughters\' vaccination status.

Our study was limited by the relatively small proportion of respondents who identified as parents of daughters aged 9--17 years. Having a larger group of parents included in the study may have provided more significant results, as many of our attitudinal results were approaching significance. However, importantly, we included both women and men in our sample. Previous studies on HPV parental attitudes have mainly focused on mothers, although with the HPV vaccination now provided to school-aged boys ([@bb0155]), fathers\' knowledge and attitudes may be increasingly important.

Furthermore, our study focused on intrapersonal factors that may be associated with HPV vaccine initiation. Healthcare provider (HCP) recommendations, along with various interpersonal and environmental influences have also been shown to be associated with initiation and are important to understand. As demonstrated across several studies ([@bb0035], [@bb0060], [@bb0110], [@bb0125], [@bb0135]), HCPs\' influence on vaccine uptake appears to often outweigh parental knowledge and attitudes.

Since acceptance of HPV vaccination varies internationally, and many adolescents are still not getting the HPV vaccine in various countries ([@bb0165]), it is important to understand why some parents choose to vaccinate their children and some parents do not in order to continue to increase vaccination uptake. Importantly, our study focuses on parental factors associated with the HPV vaccination across three countries following vaccination introduction and adds to the growing body of existing research which explores how parents\' knowledge and attitudes may influence vaccine uptake. This is the first study to directly assess parental knowledge and attitudes across different countries and between school based and non-school based programs. This understanding is important in order to target interventions aimed at improving knowledge and changing attitudes which, in turn, may help increase vaccination participation internationally and in the individual countries included in this study. In particular, US-based research has shown HCPs to be influential over parental decisions about the HPV vaccine, and this study has identified areas which could be useful to focus discussions with parents about their child receiving the HPV vaccine. Furthermore, the UK and Australia have universal health care systems with vaccination policy determined centrally, whereas in the US vaccination policy is determined on a far less coherent state-to-state basis and may therefore allow parental attitudes to be particularly influential in vaccination decisions.

5. Conclusion {#s0055}
=============

Our study demonstrates that both low and high HPV knowledge may be associated with lower rates of vaccination, with parents\' country and gender also being influential factors. It also demonstrates that parental attitudes towards the HPV vaccine differ by country and knowledge. These findings can contribute to the way the vaccine is promoted and/or administered in the future across different countries.
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[^1]: Majority in USA = white non-Hispanic, UK = white British, AUS = white Australian.

[^2]: Education was coded as follows: High: college graduate/graduate school, some college/associate degree (USA), degree/post-graduate degree, vocational/A-levels/other qualification \< degree (UK), any university education, vocational qualification (AUS); Low: high school, CED or below (USA), no formal education/GCSEs (UK), no formal education/high school (AUS).

[^3]: HPV knowledge scores ranged from 0 to 16 and was measured on the number of correct answers out of 16 questions.

[^4]: HPV vaccination knowledge score ranged from 0 to 7 and was measured on the number of correct answers out of 7.

[^5]: 8 attitude statements that were given to both groups of parents.

[^6]: Participants from the UK were not given this question, therefore 59 participants missing.

[^7]: Estimated in the USA and AUS only in a separate model adjusting for all other variables from the multivariable model.

[^8]: *p* \< 0.05.

[^9]: *p* \< 0.01.

[^10]: Row percentages for comparison across countries.

[^11]: Pearson chi-square test used[.]{.ul}

[^12]: Participants from the UK were not given this question.

[^13]: Row percentages reported for comparison across knowledge levels.

[^14]: Pearson chi-square test used.
